関連レポート

機能性食品原料の世界市場：タイプ別、用途別2029年予測

出版元：MarketsandMarkets  出版元について

発行年：2024年3月

定価：Single User License $4950 Multi User License $6650 Corporate User License $8150

ご請求は円換算（お見積り日TTSレート）となります。

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

納品形態：PDF by Email

当調査レポートは英文 342ページになります。

商品コード：MAM3578

当レポートの更新版の制作依頼、部分購入やご希望情報の追加等、ご相談可能です。

レポート紹介

プロバイオティクスの世界市場規模は2024年で712億ドル、2029年に1057億ドル、市場の平均年成長率は8.2%にて増加すると見込まれています。

レポートはプロバイオティクスの世界市場について2029年までの市場予測データ(金額US$、重量Kiloton)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（製品タイプ別市場、成分別市場、等）を中心に構成されています。また競合状況、主要企業情報（15社）、特許分析、規制状況なども加味し、プロバイオティクス市場の動向および今後成長性を詳細にレポートしています。

【レポート構成概要】
◆プロバイオティクス市場の世界市場予測2020-2029年
・市場規模(US$)
・重量（Kiloton）

◆製品タイプ別、市場-2029年
機能性食品飲料
・乳製品
・非乳飲料
・粉ミルク
・シリアル
・その他機能性食品飲料
栄養補助食品
・タブレット
・カプセル
・パウダー
・液体
・ソフトジェル
・ジェルカプセル
飼料
※(市場規模US$、重量Kiloton)　

◆成分別、市場-2029年
細菌
・乳酸菌
・ビフィズス菌
・ストレプトコッカスサーモフィルス
酵母
・サッカロミセスブラウディ
・その他酵母
※(市場規模US$)　

◆流通経路別、市場-2029年
・ハイパーマーケット、スーパーマーケット
・薬局、ドラッグストア
・専門店
・オンライン
・コンビニエンスストア、小規模小売店
※(市場規模US$)　

◆エンドユーザー別、市場-2029年
・人間
・動物
※(市場規模US$)　

◆主要国地域別市場-2029年
北米
・米国、カナダ、メキシコ
欧州
・ロシア、英国、イタリア
・ドイツ、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
南米
・ブラジル
・アルゼンチン
・その他南米
その他地域
・中東
・アフリカ
※地域別に、各種セグメント別の細分化データ掲載
※国別に、製品タイプ大分類別の細分化データ掲載、詳細は目次参照

◆市場分析
・市場ダイナミクス
・バリューチェーン分析
・サプライチェーン分析
・技術分析
・平均価格分析
・エコシステム分析/市場マップ
・貿易データ分析
・特許分析
・規制状況
・ファイブフォース分析
・ケーススタディ分析
・競合状況
・市場シェア分析

◆プロバイオティクス市場の主要企業プロフィール動向
・PROBI
・NESTLÉ
・ADM
・DANONE
・INTERNATIONAL FLAVORS & FRAGRANCES INC
・株式会社ヤクルト本社
・BIOGAIA
・森永乳業株式会社
・明治ホールディングス株式会社
・LIFEWAY FOODS, INC
・ADISSEO
・WINCLOVE PROBIOTICS
・AB-BIOTICS, SA
・APSEN FARMACÊUTICA
・LALLEMAND

その他企業
・ELANCO
・NEXTFOODS, INC
・I-HEALTH, INC
・SUJA LIFE, LLC
・RENEW LIFE FORMULAS, LLC
・BIOHM HEALTH
・SUN GENOMICS
・UNIQUE BIOTECH LTD
・SO GOOD SO YOU
・PROTOCOL FOR LIFE BALANCE
（全342頁）

Table of Contents (英文詳細目次）

1 INTRODUCTION 38
1.1 STUDY OBJECTIVES 38
1.2 MARKET DEFINITION 39
1.3 STUDY SCOPE 39
1.3.1 MARKET SEGMENTATION 39
・ FIGURE 1 PROBIOTICS MARKET SEGMENTATION 39
1.3.2 INCLUSIONS AND EXCLUSIONS 40
1.3.3 REGIONS COVERED 41
・ FIGURE 2 PROBIOTICS MARKET SEGMENTATION, BY REGION 41
1.3.4 YEARS CONSIDERED 41
・ FIGURE 3 STUDY PERIODS CONSIDERED 41
1.4 UNITS CONSIDERED 42
1.4.1 CURRENCY (VALUE UNIT) 42
・ TABLE 1 USD EXCHANGE RATES CONSIDERED, 2019–2022 42
1.4.2 VOLUME UNIT 43
1.5 STAKEHOLDERS 43
1.6 SUMMARY OF CHANGES 44
1.7 RECESSION IMPACT ANALYSIS 44

2 RESEARCH METHODOLOGY 45
2.1 RESEARCH DATA 45
・ FIGURE 4 PROBIOTICS MARKET: RESEARCH DESIGN 45
2.1.1 SECONDARY DATA 46
2.1.1.1 KEY DATA FROM SECONDARY SOURCES 46
・ FIGURE 5 KEY DATA FROM SECONDARY SOURCES 46
2.1.2 PRIMARY DATA 47
2.1.2.1 KEY PRIMARY INSIGHTS 47
・ FIGURE 6 KEY INSIGHTS FROM PRIMARY SOURCES 47
2.1.2.2 BREAKDOWN OF PRIMARY INTERVIEWS 48
・ FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION 48
2.2 MARKET SIZE ESTIMATION 49
2.2.1 BOTTOM-UP APPROACH 49
・ FIGURE 8 PROBIOTICS MARKET: BOTTOM-UP APPROACH 50
2.2.2 TOP-DOWN APPROACH 50
2.2.2.1 SUPPLY SIDE ANALYSIS 51
・ FIGURE 9 PROBIOTICS MARKET SIZE CALCULATION STEPS AND THEIR CORRESPONDING SOURCES: SUPPLY SIDE 51
・ FIGURE 10 PROBIOTICS MARKET: TOP-DOWN APPROACH 52
2.3 DATA TRIANGULATION 53
・ FIGURE 11 DATA TRIANGULATION 53
2.4 RESEARCH ASSUMPTIONS 54
2.5 RESEARCH LIMITATIONS 54
・ FIGURE 12 RESEARCH LIMITATIONS & ASSOCIATED RISKS 54
2.6 RECESSION IMPACT ON PROBIOTICS MARKET 55
2.6.1 RECESSION MACROECONOMIC INDICATORS 55
・ FIGURE 13 INDICATORS OF RECESSION 55
・ FIGURE 14 GLOBAL INFLATION RATE, 2011–2022 56
・ FIGURE 15 GLOBAL GDP, 2011–2022 (USD TRILLION) 57
・ FIGURE 16 RECESSION INDICATORS AND THEIR IMPACT ON PROBIOTICS MARKET 58
・ FIGURE 17 PROBIOTICS MARKET: EARLIER FORECAST VS RECESSION IMPACT FORECAST, 2024 58

3 EXECUTIVE SUMMARY 60
・ TABLE 2 PROBIOTICS MARKET SNAPSHOT, 2024 VS. 2029 61
・ FIGURE 18 PROBIOTICS MARKET, BY INGREDIENT, 2024 VS. 2029 (USD BILLION) 62
・ FIGURE 19 PROBIOTICS MARKET, BY PRODUCT TYPE, 2024 VS. 2029 (USD BILLION) 62
・ FIGURE 20 PROBIOTICS MARKET, BY END USER, 2024 VS. 2029 (USD BILLION) 63
・ FIGURE 21 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024 VS. 2029 (USD BILLION) 63
・ FIGURE 22 PROBIOTICS MARKET SHARE (VALUE), BY REGION, 2023 64

4 PREMIUM INSIGHTS 65
4.1 ATTRACTIVE OPPORTUNITIES IN PROBIOTICS MARKET 65
・ FIGURE 23 HEALTH BENEFITS ASSOCIATED WITH PROBIOTIC-FORTIFIED FOODS & BEVERAGES TO PROPEL MARKET 65
4.2 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE AND COUNTRY 66
・ FIGURE 24 CHINA AND FUNCTIONAL FOOD & BEVERAGES TO ACCOUNT FOR LARGEST SEGMENTAL SHARES IN ASIA PACIFIC PROBIOTICS MARKET IN 2023 66
4.3 PROBIOTICS MARKET, BY PRODUCT TYPE 66
・ FIGURE 25 FUNCTIONAL FOOD & BEVERAGES SEGMENT TO DOMINATE AMONG PROBIOTIC PRODUCT TYPES IN MARKET DURING FORECAST PERIOD 66
4.4 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY-PRODUCT SUBTYPE 67
・ FIGURE 26 DAIRY PRODUCTS TO HAVE SUBSTANTIAL LEAD OVER OTHER FUNCTIONAL FOOD & BEVERAGES WITH PROBIOTICS DURING FORECAST PERIOD 67
4.5 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL 67
・ FIGURE 27 HYPERMARKETS & SUPERMARKETS TO BE LEADING DISTRIBUTION CHANNELS OF PROBIOTICS DURING FORECAST PERIOD 67
4.6 PROBIOTICS MARKET, BY END USER 68
・ FIGURE 28 HUMAN END USE TO COMMAND LION’S SHARE OVER ANIMAL END USE OF PROBIOTICS DURING STUDY PERIOD 68
4.7 PROBIOTICS MARKET, BY INGREDIENT 68
・ FIGURE 29 BACTERIAL PROBIOTICS TO DOMINATE MARKET DURING FORECAST PERIOD 68

5 MARKET OVERVIEW 69
5.1 INTRODUCTION 69
5.2 MACROECONOMIC INDICATORS 69
5.2.1 INCREASE IN RETAIL SALES 69
・ FIGURE 30 US: RETAIL AND FOOD SERVICE SALES, 2016–2022 (USD BILLION) 70
5.2.2 GROWTH OPPORTUNITIES IN DEVELOPING REGIONS SUCH AS ASIA PACIFIC AND SOUTH AMERICA 70
・ FIGURE 31 ASIA: ANNUAL GDP GROWTH RATE, BY COUNTRY, 2022 71
5.3 MARKET DYNAMICS 71
・ FIGURE 32 MARKET DYNAMICS 71
5.3.1 DRIVERS 72
5.3.1.1 RISE IN AWARENESS ON HEALTH BENEFITS ASSOCIATED WITH PROBIOTIC-FORTIFIED FOODS 72
5.3.1.2 PARTICIPATION OF INTERNATIONAL BODIES IN R&D OF PROBIOTIC PRODUCTS 72
5.3.1.3 TECHNOLOGICAL ADVANCEMENTS IN PROBIOTIC PRODUCTS 73
5.3.2 RESTRAINTS 73
5.3.2.1 HIGH R&D COSTS FOR DEVELOPING NEW PROBIOTIC STRAINS 73
5.3.2.2 INSTANCES OF ALLERGIC REACTIONS TO SOME PROBIOTIC SUPPLEMENTS 74
5.3.2.3 STRESS FACTORS AFFECTING PROBIOTIC EFFICACY 74
5.3.3 OPPORTUNITIES 74
5.3.3.1 BAN ON USE OF ANTIBIOTIC GROWTH PROMOTERS (AGPS) IN FEED IN EU 74
5.3.3.2 REPLACEMENT OF PHARMACEUTICAL AGENTS BY PROBIOTICS 75
5.3.3.3 USE OF YEAST PROBIOTICS AS ANTIBIOTICS OR GROWTH PROMOTERS 75
5.3.4 CHALLENGES 76
5.3.4.1 COMPLEXITIES IN INTEGRATING PROBIOTICS IN FUNCTIONAL FOODS 76
5.3.4.2 INTOLERANCE OF PROBIOTICS TO STOMACH ACID AND BILE 76

6 INDUSTRY TRENDS 77
6.1 INTRODUCTION 77
6.2 VALUE CHAIN ANALYSIS 77
・ FIGURE 33 VALUE CHAIN ANALYSIS OF PROBIOTICS MARKET 78
6.2.1 RESEARCH & PRODUCT DEVELOPMENT 78
6.2.2 SOURCING 78
6.2.3 PRODUCTION & PROCESSING 79
6.2.4 PACKAGING & STORAGE 79
6.2.5 DISTRIBUTION, SALES, AND MARKETING 79
6.3 SUPPLY CHAIN ANALYSIS 79
・ FIGURE 34 SUPPLY CHAIN ANALYSIS OF PROBIOTICS MARKET 79
6.4 TECHNOLOGY ANALYSIS 80
6.4.1 KEY TECHNOLOGIES 80
6.4.1.1 MULTI-LAYER EMBEDDING 80
6.4.1.2 MICROENCAPSULATED POWDER FOR PROBIOTICATION IN FOOD PRODUCTS 81
6.4.2 COMPLEMENTARY TECHNOLOGY 81
6.4.2.1 PROBIOTICS AND ARTIFICIAL INTELLIGENCE 81
6.5 PRICING ANALYSIS 81
6.5.1 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY FUNCTIONAL FOOD & BEVERAGES 81
・ TABLE 3 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY FUNCTIONAL FOOD & BEVERAGE PRODUCT, 2024 (USD/TON) 82
6.5.2 AVERAGE SELLING PRICE TRENDS, BY PRODUCT TYPE 82
・ FIGURE 35 AVERAGE SELLING PRICE TRENDS, BY PRODUCT TYPE, 2022–2024 (USD/TON) 82
・ FIGURE 36 AVERAGE SELLING PRICE TRENDS, BY PRODUCT TYPE, 2021-2024 (USD/TON) 83
・ TABLE 4 AVERAGE SELLING PRICE TRENDS FOR FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2022–2024 (USD/TON) 83
・ TABLE 5 AVERAGE SELLING PRICE TRENDS FOR DIETARY SUPPLEMENTS, BY REGION, 2022–2024 (USD/TON) 83
・ TABLE 6 AVERAGE SELLING PRICE TRENDS FOR FEED, BY REGION, 2022–2024 (USD/TON) 84
6.6 ECOSYSTEM ANALYSIS/MARKET MAP 84
6.6.1 SUPPLY-SIDE ANALYSIS 84
6.6.2 DEMAND SIDE ANALYSIS 84
・ FIGURE 37 PROBIOTICS MARKET MAPPING 85
・ FIGURE 38 ECOSYSTEM MAPPING OF PROBIOTICS MARKET 85
・ TABLE 7 PROBIOTICS MARKET: SUPPLY CHAIN (ECOSYSTEM) 86
6.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 87
・ FIGURE 39 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 87
6.8 TRADE DATA ANALYSIS 88
・ TABLE 8 EXPORT DATA OF HS CODE 300290 FOR KEY COUNTRIES, 2021–2023 (KG) 88
・ TABLE 9 IMPORT DATA OF HS CODE 300290 FOR KEY COUNTRIES, 2021–2023 (KG) 88
6.9 PATENT ANALYSIS 89
・ FIGURE 40 NUMBER OF PATENTS GRANTED BETWEEN 2013 AND 2023 89
・ FIGURE 41 TOP 10 INVENTORS WITH HIGHEST NUMBER OF PATENT DOCUMENTS 90
・ TABLE 10 KEY PATENTS IN PROBIOTICS MARKET, 2023–2024 91
6.10 KEY CONFERENCES & EVENTS 93
6.11 REGULATORY LANDSCAPE 94
6.11.1 PERTINENT REGULATORY FACTORS 94
6.11.1.1 NORTH AMERICA 94
6.11.1.1.1 US 94
6.11.1.1.2 CANADA 94
6.11.1.2 EUROPE 95
6.11.1.3 ASIA PACIFIC 95
6.11.1.3.1 JAPAN 95
6.11.1.3.2 AUSTRALIA AND NEW ZEALAND 96
6.11.1.3.3 INDIA 96
6.11.1.4 SOUTH AMERICA 97
6.11.1.4.1 BRAZIL 97
6.11.1.5 ROW 97
6.11.1.5.1 MIDDLE EAST 97
6.11.1.5.2 AFRICA (SOUTH AFRICA) 97
6.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS 98
・ TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
・ TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
・ TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99
6.12 PORTER’S FIVE FORCES ANALYSIS 99
・ TABLE 15 PROBIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 99
6.12.1 THREAT OF NEW ENTRANTS 100
6.12.2 THREAT OF SUBSTITUTES 100
6.12.3 BARGAINING POWER OF SUPPLIERS 100
6.12.4 BARGAINING POWER OF BUYERS 100
6.12.5 INTENSITY OF COMPETITIVE RIVALRY 101
6.13 CASE STUDIES 101
6.13.1 ADM: PROMOTED METABOLIC HEALTH WITH BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS CECT 8145 BPL1 101
6.13.2 MAGNITUDE BIOSCIENCES AND AB BIOTEK HNH: PROBIOTIC DEVELOPMENT WITH ETHICAL AND HIGH-THROUGHPUT TESTING 101
6.14 KEY STAKEHOLDERS AND BUYING CRITERIA 102
6.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 102
・ FIGURE 42 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR KEY PRODUCT TYPE 102
・ TABLE 16 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP THREE PRODUCT TYPES 102
6.14.2 BUYING CRITERIA 103
・ TABLE 17 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS, BY PRODUCT TYPE 103
・ FIGURE 43 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS, BY PRODUCT TYPE 103
6.15 INVESTMENT AND FUNDING SCENARIO 104
・ FIGURE 44 INVESTMENT AND FUNDING SCENARIO 104

7 PROBIOTICS MARKET, BY PRODUCT TYPE 105
7.1 INTRODUCTION 106
・ FIGURE 45 PROBIOTICS MARKET, BY PRODUCT TYPE, 2024 VS. 2029 (USD BILLION) 106
・ TABLE 18 PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION) 107
・ TABLE 19 PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION) 107
・ TABLE 20 PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT) 107
・ TABLE 21 PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT) 108
7.2 FUNCTIONAL FOOD & BEVERAGES 108
・ FIGURE 46 US: PREFERRED SOURCES OF PROBIOTICS CONSUMPTION, 2022 109
・ TABLE 22 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2020–2023 (USD BILLION) 109
・ TABLE 23 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2024–2029 (USD BILLION) 110
・ TABLE 24 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2020–2023 (KT) 110
・ TABLE 25 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2024–2029 (KT) 110
・ TABLE 26 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION) 111
・ TABLE 27 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION) 111
7.2.1 DAIRY PRODUCTS 111
7.2.1.1 POPULARITY OF DAIRY PRODUCTS AND HIGH COMPATIBILITY WITH PROBIOTICS 111
7.2.2 NONDAIRY BEVERAGES 112
7.2.2.1 NEED TO CATER TO INCREASING LACTOSE-INTOLERANT CONSUMERS 112
7.2.3 INFANT FORMULA 112
7.2.3.1 RISE IN CONSUMPTION OF FORTIFIED INFANT NUTRITION 112
7.2.4 CEREALS 113
7.2.4.1 RISE IN DEMAND FOR READY-TO-EAT FOOD ITEMS WITH CHANGING CONSUMER LIFESTYLES 113
7.2.5 OTHER FUNCTIONAL FOOD & BEVERAGES 113
7.3 DIETARY SUPPLEMENTS 114
・ TABLE 28 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2020–2023 (USD BILLION) 114
・ TABLE 29 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2024–2029 (USD BILLION) 115
・ TABLE 30 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2020–2023 (KT) 115
・ TABLE 31 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2024–2029 (KT) 115
・ TABLE 32 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION) 116
・ TABLE 33 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION) 116
7.3.1 ・ TABLETS 116
7.3.1.1 HIGH SHELF-LIFE, AFFORDABILITY, AND WIDE RANGE OF DOSAGE PATTERNS 116
7.3.2 CAPSULES 117
7.3.2.1 RAPID ABSORPTION OF NUTRIENTS AND HIGHLY CUSTOMIZABLE 117
7.3.3 POWDERS 117
7.3.3.1 EASY RELEASE OF ACTIVE INGREDIENTS AND HIGH STABILITY 117
7.3.4 LIQUIDS 118
7.3.4.1 EASY CONSUMPTION, GREATER HOMOGENEITY, AND HIGH ABSORPTION IN BLOODSTREAMS 118
7.3.5 SOFT GELS 118
7.3.5.1 RELATIVELY LOW COST AND IMPROVED BIOAVAILABILITY 118
7.3.6 GEL CAPS 119
7.3.6.1 PURE-PROTEIN, BENIGN ORAL DOSAGE FORM 119
7.4 FEED 119
7.4.1 RISE IN TREND FOR PROVIDING PETS WITH HIGH-QUALITY AND HEALTHY WET AND DRY MEALS 119
・ TABLE 34 PROBIOTICS MARKET IN FEED, BY REGION, 2020–2023 (USD BILLION) 120
・ TABLE 35 PROBIOTICS MARKET IN FEED, BY REGION, 2024–2029 (USD BILLION) 120
・ TABLE 36 PROBIOTICS MARKET IN FEED, BY REGION, 2020–2023 (KT) 121
・ TABLE 37 PROBIOTICS MARKET IN FEED, BY REGION, 2024–2029 (KT) 121

8 PROBIOTICS MARKET, BY INGREDIENT 122
8.1 INTRODUCTION 123
・ TABLE 38 DIVERSITY OF PROBIOTICS 123
・ TABLE 39 HEALTH BENEFITS OF PROBIOTIC MICROORGANISMS 124
・ FIGURE 47 PROBIOTICS MARKET, BY INGREDIENT, 2024 VS. 2029 (USD BILLION) 126
・ TABLE 40 PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION) 127
・ TABLE 41 PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION) 127
8.2 BACTERIA 127
・ TABLE 42 BACTERIAL PROBIOTICS MARKET, BY REGION, 2020–2023 (USD BILLION) 128
・ TABLE 43 BACTERIAL PROBIOTICS MARKET, BY REGION, 2024–2029 (USD BILLION) 128
・ TABLE 44 BACTERIAL PROBIOTICS MARKET, BY TYPE, 2020–2023 (USD BILLION) 128
・ TABLE 45 BACTERIAL PROBIOTICS MARKET, BY TYPE, 2024–2029 (USD BILLION) 128
8.2.1 LACTOBACILLI 129
8.2.1.1 LACTOBACILLUS ACIDOPHILUS 129
8.2.1.1.1 RISE IN CONSUMPTION OF FERMENTED FOODS, CHEESE, AND YOGURT 129
8.2.1.2 LACTOBACILLUS RHAMNOSUS 129
8.2.1.2.1 ABILITY TO ENDURE HARSH GUT CONDITIONS AND REDUCED RISK OF ANTIBIOTIC-ASSOCIATED INTESTINAL SYMPTOMS 129
8.2.1.3 LACTOBACILLUS CASEI 130
8.2.1.3.1 BROAD-SPECTRUM ACTION AGAINST DISEASES CAUSED BY GASTROINTESTINAL PATHOGENIC BACTERIA 130
8.2.1.4 LACTOBACILLUS REUTERI 130
8.2.1.4.1 OPPORTUNITIES IN PREVENTIVE AND THERAPEUTIC AVENUES AGAINST INFLAMMATORY DISEASES 130
8.2.2 BIFIDOBACTERIUM 131
8.2.2.1 BENEFITS AGAINST CHRONIC AILMENTS, ESPECIALLY IN INFANT GUT HEALTH 131
8.2.3 STREPTOCOCCUS THERMOPHILUS 131
8.2.3.1 GROWING APPLICATION OF STREPTOCOCCUS THERMOPHILUS IN FOOD AND FEED INDUSTRIES 131
8.3 YEAST 132
・ TABLE 46 YEAST-BASED PROBIOTICS MARKET, BY REGION, 2020–2023 (USD BILLION) 133
・ TABLE 47 YEAST-BASED PROBIOTICS MARKET, BY REGION, 2024–2029 (USD BILLION) 133
・ TABLE 48 YEAST-BASED PROBIOTICS MARKET, BY TYPE, 2020–2023 (USD BILLION) 133
・ TABLE 49 YEAST-BASED PROBIOTICS MARKET, BY TYPE, 2024–2029 (USD BILLION) 133
・ TABLE 50 BENEFICIAL EFFECTS OF YEAST 134
8.3.1 SACCHAROMYCES BOULARDII 135
8.3.1.1 GI STRESS-RESISTANCE KEY IN MAINTAINING GUT FLORA BALANCE 135
8.3.2 OTHER YEASTS 135

9 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL 136
9.1 INTRODUCTION 137
・ FIGURE 48 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024 VS. 2029 (USD BILLION) 137
・ TABLE 51 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION) 137
・ TABLE 52 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION) 138
9.2 HYPERMARKETS/SUPERMARKETS 138
9.2.1 EXPANSION OF SUPERMARKETS IN ASIA PACIFIC 138
・ TABLE 53 PROBIOTICS MARKET IN HYPERMARKETS/SUPERMARKETS, BY REGION, 2020–2023 (USD BILLION) 139
・ TABLE 54 PROBIOTICS MARKET IN HYPERMARKETS/SUPERMARKETS, BY REGION, 2024–2029 (USD BILLION) 139
9.3 PHARMACIES/DRUGSTORES 139
9.3.1 RISE IN AWARENESS FOR PROBIOTIC SUPPLEMENTS IN DEVELOPED COUNTRIES TO POPULARIZE PHARMACIES 139
・ TABLE 55 PROBIOTICS MARKET IN PHARMACIES/DRUGSTORES, BY REGION, 2020–2023 (USD BILLION) 140
・ TABLE 56 PROBIOTICS MARKET IN PHARMACIES/DRUGSTORES, BY REGION, 2024–2029 (USD BILLION) 140
9.4 SPECIALTY STORES 141
9.4.1 PROBIOTIC SALES FUELED BY PROPER STORAGE AND TRANSPARENT LABELING 141
・ TABLE 57 PROBIOTICS MARKET IN SPECIALTY STORES, BY REGION, 2020–2023 (USD BILLION) 141
・ TABLE 58 PROBIOTICS MARKET IN SPECIALTY STORES, BY REGION, 2024–2029 (USD BILLION) 141
9.5 ONLINE 142
9.5.1 ONLINE SALES SURGE DUE TO CONVENIENCE, HEALTH FOCUS, AND STRONG BRAND LOYALTY AMONG CONSUMERS 142
・ TABLE 59 PROBIOTICS MARKET IN ONLINE CHANNELS, BY REGION, 2020–2023 (USD BILLION) 142
・ TABLE 60 PROBIOTICS MARKET IN ONLINE CHANNELS, BY REGION, 2024–2029 (USD BILLION) 142
9.6 CONVENIENCE STORES/SMALL RETAIL FORMATS 143
9.6.1 EASY ACCESS FOR CONSUMERS ENCOURAGING PURCHASE 143
・ TABLE 61 PROBIOTICS MARKET IN CONVENIENCE STORES/SMALL RETAIL FORMATS, BY REGION, 2020–2023 (USD BILLION) 143
・ TABLE 62 PROBIOTICS MARKET IN CONVENIENCE STORES/SMALL RETAIL FORMATS, BY REGION, 2024–2029 (USD BILLION) 143

10 PROBIOTICS MARKET, BY END USER 144
10.1 INTRODUCTION 145
・ FIGURE 49 HUMAN CONSUMPTION TO DOMINATE MARKET FROM 2024 TO 2029 (USD BILLION) 145
・ TABLE 63 PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION) 146
・ TABLE 64 PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION) 146
10.2 HUMAN 146
10.2.1 RISING TREND OF CONSUMING FUNCTIONAL FOODS DUE TO HEALTH CONSCIOUSNESS 146
・ FIGURE 50 FREQUENCY OF PROBIOTIC CONSUMPTION AMONG USERS 147
・ TABLE 65 PROBIOTICS MARKET FOR HUMAN USE, BY REGION, 2020–2023 (USD BILLION) 147
・ TABLE 66 PROBIOTICS MARKET FOR HUMAN USE, BY REGION, 2024–2029 (USD BILLION) 148
10.3 ANIMAL 148
10.3.1 BAN ON SYNTHETIC ANTIBIOTICS TO BOOST MARKET IN FEED 148
・ TABLE 67 BENEFITS ASSOCIATED WITH ADMINISTRATION OF PROBIOTICS IN ANIMAL FEED 149
・ TABLE 68 PROBIOTICS MARKET FOR ANIMAL USE, BY REGION, 2020–2023 (USD BILLION) 149
・ TABLE 69 PROBIOTICS MARKET FOR ANIMAL USE, BY REGION, 2024–2029 (USD BILLION) 150

11 PROBIOTICS MARKET, BY REGION 151
11.1 INTRODUCTION 152
・ FIGURE 51 RAPIDLY GROWING MARKETS TO EMERGE AS NEW HOT SPOTS 152
・ TABLE 70 PROBIOTICS MARKET, BY REGION, 2020–2023 (USD BILLION) 153
・ TABLE 71 PROBIOTICS MARKET, BY REGION, 2024–2029 (USD BILLION) 153
・ TABLE 72 PROBIOTICS MARKET, BY REGION, 2020–2023 (KT) 153
・ TABLE 73 PROBIOTICS MARKET, BY REGION, 2024–2029 (KT) 154
11.2 NORTH AMERICA 154
11.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS 154
・ FIGURE 52 NORTH AMERICA: INFLATION DATA, BY KEY COUNTRY, 2017–2022 155
・ FIGURE 53 NORTH AMERICA: RECESSION IMPACT ANALYSIS 156
・ TABLE 74 NORTH AMERICA: PROBIOTICS MARKET, BY COUNTRY, 2020–2023 (USD BILLION) 156
・ TABLE 75 NORTH AMERICA: PROBIOTICS MARKET, BY COUNTRY, 2024–2029 (USD BILLION) 156
・ TABLE 76 NORTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION) 157
・ TABLE 77 NORTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION) 157
・ TABLE 78 NORTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT) 157
・ TABLE 79 NORTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT) 157
・ TABLE 80 NORTH AMERICA: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION) 158
・ TABLE 81 NORTH AMERICA: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION) 158
・ TABLE 82 NORTH AMERICA: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION) 158
・ TABLE 83 NORTH AMERICA: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION) 159
・ TABLE 84 NORTH AMERICA: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION) 159
・ TABLE 85 NORTH AMERICA: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION) 159
・ TABLE 86 NORTH AMERICA: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION) 159
・ TABLE 87 NORTH AMERICA: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION) 160
11.2.2 US 160
11.2.2.1 RISE IN DIGESTIVE HEALTH AWARENESS 160
・ TABLE 88 US: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 161
・ TABLE 89 US: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 161
11.2.3 CANADA 161
11.2.3.1 DEMAND FOR HIGH-QUALITY AND INNOVATIVE FEED PRODUCTS TO ACCELERATE PROBIOTICS PRODUCTION AND CONSUMPTION 161
・ TABLE 90 CANADA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 162
・ TABLE 91 CANADA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 162
11.2.4 MEXICO 162
11.2.4.1 CONSUMER INCLINATION TOWARD HEALTHY DIETS 162
・ TABLE 92 MEXICO: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 163
・ TABLE 93 MEXICO: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 163
11.3 EUROPE 163
・ FIGURE 54 EUROPE: MARKET SNAPSHOT 164
11.3.1 EUROPE: RECESSION IMPACT ANALYSIS 165
・ FIGURE 55 EUROPE: INFLATION DATA, BY KEY COUNTRY, 2017–2022 166
・ FIGURE 56 EUROPE: RECESSION IMPACT ANALYSIS 166
・ TABLE 94 EUROPE: PROBIOTICS MARKET, BY COUNTRY, 2020–2023 (USD BILLION) 167
・ TABLE 95 EUROPE: PROBIOTICS MARKET, BY COUNTRY, 2024–2029 (USD BILLION) 167
・ TABLE 96 EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION) 167
・ TABLE 97 EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION) 168
・ TABLE 98 EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT) 168
・ TABLE 99 EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT) 168
・ TABLE 100 EUROPE: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION) 169
・ TABLE 101 EUROPE: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION) 169
・ TABLE 102 EUROPE: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION) 169
・ TABLE 103 EUROPE: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION) 170
・ TABLE 104 EUROPE: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION) 170
・ TABLE 105 EUROPE: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION) 170
・ TABLE 106 EUROPE: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION) 170
・ TABLE 107 EUROPE: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION) 171
11.3.2 RUSSIA 171
11.3.2.1 HIGHLY REGULATED PROBIOTIC LANDSCAPE 171
・ TABLE 108 RUSSIA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 171
・ TABLE 109 RUSSIA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 172
11.3.3 UK 172
11.3.3.1 SHIFT TOWARD NATURAL FOODS THAT SUPPORT DIGESTIVE HEALTH 172
・ TABLE 110 UK: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 173
・ TABLE 111 UK: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 173
11.3.4 ITALY 173
11.3.4.1 PREFERENCE FOR CHEESE AND AWARENESS ABOUT HEALTH BENEFITS OF PROBIOTICS 173
・ TABLE 112 ITALY: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 174
・ TABLE 113 ITALY: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 174
11.3.5 GERMANY 174
11.3.5.1 PREFERENCE FOR PROBIOTIC YOGURTS AND YOGURT DRINKS AND OPPORTUNITY FOR USE IN POULTRY FEED 174
・ TABLE 114 GERMANY: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 175
・ TABLE 115 GERMANY: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 175
11.3.6 SPAIN 175
11.3.6.1 GROWING INTEREST IN HEALTH AND WELLNESS PRODUCTS AMONG CONSUMERS TO SPUR INVESTMENT BY COMPANIES 175
・ TABLE 116 SPAIN: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 176
・ TABLE 117 SPAIN: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 176
11.3.7 REST OF EUROPE 176
・ TABLE 118 REST OF EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 177
・ TABLE 119 REST OF EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 177
11.4 ASIA PACIFIC 177
・ FIGURE 57 ASIA PACIFIC: MARKET SNAPSHOT 178
11.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS 179
・ FIGURE 58 ASIA PACIFIC: INFLATION DATA, BY KEY COUNTRY, 2017–2022 179
・ FIGURE 59 ASIA PACIFIC: RECESSION IMPACT ANALYSIS 180
・ TABLE 120 ASIA PACIFIC: PROBIOTICS MARKET, BY COUNTRY/REGION, 2020–2023 (USD BILLION) 180
・ TABLE 121 ASIA PACIFIC: PROBIOTICS MARKET, BY COUNTRY/REGION, 2024–2029 (USD BILLION) 181
・ TABLE 122 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION) 181
・ TABLE 123 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION) 181
・ TABLE 124 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT) 181
・ TABLE 125 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT) 182
・ TABLE 126 ASIA PACIFIC: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION) 182
・ TABLE 127 ASIA PACIFIC: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION) 182
・ TABLE 128 ASIA PACIFIC: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION) 183
・ TABLE 129 ASIA PACIFIC: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION) 183
・ TABLE 130 ASIA PACIFIC: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION) 183
・ TABLE 131 ASIA PACIFIC: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION) 184
・ TABLE 132 ASIA PACIFIC: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION) 184
・ TABLE 133 ASIA PACIFIC: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION) 184
11.4.2 CHINA 184
11.4.2.1 STRATEGIC MOVES BY PLAYERS TO TAP HIGH SALES POTENTIAL OF PROBIOTICS 184
・ TABLE 134 CHINA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 185
・ TABLE 135 CHINA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 185
11.4.3 JAPAN 186
11.4.3.1 FOCUS ON DIGESTIVE WELL-BEING OF AGING POPULATION 186
・ TABLE 136 JAPAN: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 186
・ TABLE 137 JAPAN: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 186
11.4.4 INDIA 187
11.4.4.1 INCREASED FOCUS ON WOMEN’S NUTRITION AND POST-COVID-19 CONSUMER PREFERENCE FOR FUNCTIONAL FOOD 187
・ TABLE 138 INDIA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 187
・ TABLE 139 INDIA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 187
11.4.5 AUSTRALIA & NEW ZEALAND 188
11.4.5.1 AGING POPULATION AND CONSUMER AWARENESS TO DRIVE CLINICAL TRIALS AND RETAIL SALES 188
・ TABLE 140 AUSTRALIA & NEW ZEALAND: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 188
・ TABLE 141 AUSTRALIA & NEW ZEALAND: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 188
11.4.6 REST OF ASIA PACIFIC 189
・ TABLE 142 REST OF ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 189
・ TABLE 143 REST OF ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 189
11.5 SOUTH AMERICA 190
11.5.1 SOUTH AMERICA: RECESSION IMPACT ANALYSIS 190
・ FIGURE 60 SOUTH AMERICA: INFLATION DATA, BY COUNTRY, 2017–2022 191
・ FIGURE 61 SOUTH AMERICA: RECESSION IMPACT ANALYSIS 191
・ TABLE 144 SOUTH AMERICA: PROBIOTICS MARKET, BY COUNTRY, 2020–2023 (USD BILLION) 192
・ TABLE 145 SOUTH AMERICA: PROBIOTICS MARKET, BY COUNTRY, 2024–2029 (USD BILLION) 192
・ TABLE 146 SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION) 192
・ TABLE 147 SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION) 193
・ TABLE 148 SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT) 193
・ TABLE 149 SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT) 193
・ TABLE 150 SOUTH AMERICA: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION) 194
・ TABLE 151 SOUTH AMERICA: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION) 194
・ TABLE 152 SOUTH AMERICA: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION) 194
・ TABLE 153 SOUTH AMERICA: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION) 195
・ TABLE 154 SOUTH AMERICA: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION) 195
・ TABLE 155 SOUTH AMERICA: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION) 195
・ TABLE 156 SOUTH AMERICA: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION) 195
・ TABLE 157 SOUTH AMERICA: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION) 196
11.5.2 BRAZIL 196
11.5.2.1 RISE IN HEALTH AWARENESS AND MEAT EXPORTS TO EU 196
・ TABLE 158 BRAZIL: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 196
・ TABLE 159 BRAZIL: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 197
11.5.3 ARGENTINA 197
11.5.3.1 INCREASE IN INDUSTRIALIZATION OF MEAT PROCESSING AND DAIRY PRODUCTIVITY 197
・ TABLE 160 ARGENTINA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 198
・ TABLE 161 ARGENTINA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 198
11.5.4 REST OF SOUTH AMERICA 198
・ TABLE 162 REST OF SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 198
・ TABLE 163 REST OF SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 199
11.6 REST OF THE WORLD (ROW) 199
11.6.1 ROW: RECESSION IMPACT ANALYSIS 199
・ FIGURE 62 ROW: INFLATION DATA, BY SUBREGION, 2017–2022 200
・ FIGURE 63 ROW: RECESSION IMPACT ANALYSIS 200
・ TABLE 164 ROW: PROBIOTICS MARKET, BY REGION, 2020–2023 (USD BILLION) 201
・ TABLE 165 ROW: PROBIOTICS MARKET, BY REGION, 2024–2029 (USD BILLION) 201
・ TABLE 166 ROW: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION) 201
・ TABLE 167 ROW: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION) 201
・ TABLE 168 ROW: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT) 202
・ TABLE 169 ROW: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT) 202
・ TABLE 170 ROW: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION) 202
・ TABLE 171 ROW: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION) 203
・ TABLE 172 ROW: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION) 203
・ TABLE 173 ROW: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION) 203
・ TABLE 174 ROW: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION) 204
・ TABLE 175 ROW: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION) 204
・ TABLE 176 ROW: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION) 204
・ TABLE 177 ROW: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION) 204
11.6.2 MIDDLE EAST 205
11.6.2.1 DEMAND FOR QUALITY FEED, HIGH CONSUMPTION OF FEED, AND DEMAND FOR YOGURT 205
・ TABLE 178 MIDDLE EAST: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 205
・ TABLE 179 MIDDLE EAST: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 205
11.6.3 AFRICA 206
11.6.3.1 INVESTMENTS IN PHARMACEUTICAL COMPANIES TO INCREASE WITH INTRA-AFRICAN TRADE 206
・ TABLE 180 AFRICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 206
・ TABLE 181 AFRICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 206

12 COMPETITIVE LANDSCAPE 207
12.1 OVERVIEW 207
12.2 SEGMENTAL REVENUE ANALYSIS 208
・ FIGURE 64 SEGMENTAL REVENUE ANALYSIS OF KEY MARKET PLAYERS, 2018–2022 (USD BILLION) 208
12.3 MARKET SHARE ANALYSIS 209
・ TABLE 182 PROBIOTICS MARKET: DEGREE OF COMPETITION (COMPETITIVE) 209
12.4 KEY PLAYERS’ STRATEGIES/RIGHT TO WIN 210
・ TABLE 183 STRATEGIES ADOPTED BY KEY PLAYERS IN PROBIOTICS MARKET 210
12.5 COMPANY VALUATION AND FINANCIAL METRICS 212
・ FIGURE 65 PROBIOTICS MARKET: COMPANY VALUATION (USD BILLION) 212
・ FIGURE 66 PROBIOTICS MARKET: EV/EBITDA, 2022 (USD BILLION) 212
12.6 BRAND/PRODUCT COMPARISON 213
・ FIGURE 67 PROBIOTICS MARKET: BRAND/PRODUCT COMPARISON 213
12.6.1 DIVERSE PROBIOTIC SOLUTIONS FUELING MARKET GROWTH 214
12.6.1.1 NESTLÉ CERELAC 214
12.6.1.2 DANONE’S ACTIVIA 214
12.6.1.3 YAKULT 214
12.6.1.4 LG21 BY MEIJI HOLDING INC. 214
12.6.1.5 HOWARU BY IFF HEALTH 214
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS 215
12.7.1 STARS 215
12.7.2 EMERGING LEADERS 215
12.7.3 PERVASIVE PLAYERS 215
12.7.4 PARTICIPANTS 216
・ FIGURE 68 PROBIOTICS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2023 216
12.7.5 COMPANY FOOTPRINT: KEY PLAYERS 217
12.7.5.1 OVERALL COMPANY FOOTPRINT 217
・ FIGURE 69 PROBIOTICS MARKET: OVERALL COMPANY FOOTPRINT FOR KEY PLAYERS, 2023 217
12.7.5.2 PRODUCT TYPE FOOTPRINT 218
・ TABLE 184 PROBIOTICS MARKET: PRODUCT TYPE FOOTPRINT FOR KEY PLAYERS, 2023 218
12.7.5.3 END USER FOOTPRINT 218
・ TABLE 185 PROBIOTICS MARKET: END USER FOOTPRINT FOR KEY PLAYERS, 2023 218
12.7.5.4 REGIONAL FOOTPRINT 219
・ TABLE 186 PROBIOTICS MARKET: REGIONAL FOOTPRINT FOR KEY PLAYERS, 2023 219
12.8 COMPANY EVALUATION MATRIX: STARTUP/SMES 220
12.8.1 PROGRESSIVE COMPANIES 220
12.8.2 RESPONSIVE COMPANIES 220
12.8.3 DYNAMIC COMPANIES 220
12.8.4 STARTING BLOCKS 220
・ FIGURE 70 PROBIOTICS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2023 221
12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES 222
12.8.5.1 DETAILED LIST OF KEY STARTUP/SMES 222
・ TABLE 187 PROBIOTICS MARKET: KEY STARTUP/SMES, 2023 222
12.8.5.2 COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES 223
・ TABLE 188 PROBIOTICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES 223
12.9 COMPETITIVE SCENARIO AND TRENDS 223
12.9.1 PRODUCT LAUNCHES 223
・ TABLE 189 PROBIOTICS MARKET: PRODUCT LAUNCHES, JANUARY 2019–FEBRUARY 2024 223
12.9.2 DEALS 227
・ TABLE 190 PROBIOTICS MARKET: DEALS, JANUARY 2019–FEBRUARY 2024 227
12.9.3 OTHERS 236
・ TABLE 191 PROBIOTICS MARKET: EXPANSIONS, JANUARY 2019–FEBRUARY 2024 236
・ TABLE 192 PROBIOTICS MARKET: OTHERS, JANUARY 2019–FEBRUARY 2024 239

13 COMPANY PROFILES 240
13.1 KEY PLAYERS 240
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
13.1.1 PROBI 240
・ TABLE 193 PROBI: BUSINESS OVERVIEW 240
・ FIGURE 71 PROBI: COMPANY SNAPSHOT 241
・ TABLE 194 PROBI: PRODUCTS/SOLUTIONS/SERVICES OFFERED 241
・ TABLE 195 PROBI: PRODUCT LAUNCHES 243
・ TABLE 196 PROBI: DEALS 243
13.1.2 NESTLÉ 246
・ TABLE 197 NESTLÉ: BUSINESS OVERVIEW 246
・ FIGURE 72 NESTLÉ: COMPANY SNAPSHOT 247
・ TABLE 198 NESTLÉ: PRODUCTS/SOLUTIONS/SERVICES OFFERED 248
・ TABLE 199 NESTLÉ: PRODUCT LAUNCHES 249
・ TABLE 200 NESTLÉ: DEALS 250
13.1.3 ADM 252
・ TABLE 201 ADM: BUSINESS OVERVIEW 252
・ FIGURE 73 ADM: COMPANY SNAPSHOT 253
・ TABLE 202 ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED 253
・ TABLE 203 ADM: DEALS 255
・ TABLE 204 ADM: EXPANSIONS 256
13.1.4 DANONE 258
・ TABLE 205 DANONE: BUSINESS OVERVIEW 258
・ FIGURE 74 DANONE: COMPANY SNAPSHOT 259
・ TABLE 206 DANONE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 259
・ TABLE 207 DANONE: PRODUCT LAUNCHES 260
・ TABLE 208 DANONE: EXPANSIONS 261
13.1.5 INTERNATIONAL FLAVORS & FRAGRANCES INC. 263
・ TABLE 209 INTERNATIONAL FLAVORS & FRAGRANCES INC.: BUSINESS OVERVIEW 263
・ FIGURE 75 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT 264
・ TABLE 210 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 264
・ TABLE 211 INTERNATIONAL FLAVORS & FRAGRANCES INC.: DEALS 265
・ TABLE 212 INTERNATIONAL FLAVORS & FRAGRANCES INC.: EXPANSIONS 266
13.1.6 YAKULT HONSHA CO., LTD. 268
・ TABLE 213 YAKULT HONSHA CO., LTD.: BUSINESS OVERVIEW 268
・ FIGURE 76 YAKULT HONSHA CO., LTD.: COMPANY SNAPSHOT 269
・ TABLE 214 YAKULT HONSHA CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 269
・ TABLE 215 YAKULT HONSHA CO., LTD.: PRODUCT LAUNCHES 270
・ TABLE 216 YAKULT HONSHA CO., LTD.: DEALS 271
・ TABLE 217 YAKULT HONSHA CO., LTD.: EXPANSIONS 272
13.1.7 BIOGAIA 274
・ TABLE 218 BIOGAIA: BUSINESS OVERVIEW 274
・ FIGURE 77 BIOGAIA: COMPANY SNAPSHOT 275
・ TABLE 219 BIOGAIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 275
・ TABLE 220 BIOGAIA: PRODUCT LAUNCHES 277
・ TABLE 221 BIOGAIA: DEALS 278
・ TABLE 222 BIOGAIA: EXPANSIONS 279
13.1.8 MORINAGA MILK INDUSTRY CO., LTD. 280
・ TABLE 223 MORINAGA MILK INDUSTRY CO., LTD.: BUSINESS OVERVIEW 280
・ FIGURE 78 MORINAGA MILK INDUSTRY CO., LTD.: COMPANY SNAPSHOT 281
・ TABLE 224 MORINAGA MILK INDUSTRY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 281
・ TABLE 225 MORINAGA MILK INDUSTRY CO., LTD.: PRODUCT LAUNCHES 282
・ TABLE 226 MORINAGA MILK INDUSTRY CO., LTD.: OTHERS 283
・ TABLE 227 MORINAGA MILK INDUSTRY CO., LTD.: EXPANSIONS 284
13.1.9 MEIJI HOLDINGS CO., LTD. 286
・ TABLE 228 MEIJI HOLDINGS CO., LTD.: BUSINESS OVERVIEW 286
・ FIGURE 79 MEIJI HOLDINGS CO., LTD.: COMPANY SNAPSHOT 287
・ TABLE 229 MEIJI HOLDINGS CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 287
13.1.10 LIFEWAY FOODS, INC. 289
・ TABLE 230 LIFEWAY FOODS, INC.: BUSINESS OVERVIEW 289
・ FIGURE 80 LIFEWAY FOODS, INC.: COMPANY SNAPSHOT 290
・ TABLE 231 LIFEWAY FOODS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 290
・ TABLE 232 LIFEWAY FOODS, INC.: DEALS 295
13.1.11 ADISSEO 297
・ TABLE 233 ADISSEO: BUSINESS OVERVIEW 297
・ FIGURE 81 ADISSEO: COMPANY SNAPSHOT 298
・ TABLE 234 ADISSEO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 298
13.1.12 WINCLOVE PROBIOTICS 300
・ TABLE 235 WINCLOVE PROBIOTICS: BUSINESS OVERVIEW 300
・ TABLE 236 WINCLOVE PROBIOTICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 300
・ TABLE 237 WINCLOVE PROBIOTICS: DEALS 302
・ TABLE 238 WINCLOVE PROBIOTICS: EXPANSIONS 302
13.1.13 AB-BIOTICS, S.A. 304
・ TABLE 239 AB-BIOTICS, S.A.: BUSINESS OVERVIEW 304
・ TABLE 240 AB-BIOTICS, S.A.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 304
・ TABLE 241 AB-BIOTICS, S.A.: DEALS 306
13.1.14 APSEN FARMACÊUTICA 308
・ TABLE 242 APSEN FARMACÊUTICA: BUSINESS OVERVIEW 308
・ TABLE 243 APSEN FARMACÊUTICA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 308
・ TABLE 244 APSEN FARMACÊUTICA: PRODUCT LAUNCHES 309
・ TABLE 245 APSEN FARMACÊUTICA: DEALS 309
13.1.15 LALLEMAND 310
・ TABLE 246 LALLEMAND: BUSINESS OVERVIEW 310
・ TABLE 247 LALLEMAND: PRODUCTS/SOLUTIONS/SERVICES OFFERED 311
・ TABLE 248 LALLEMAND: DEALS 311
・ TABLE 249 LALLEMAND: EXPANSIONS 312
13.2 STARTUP/SME PLAYERS 314
13.2.1 ELANCO 314
・ TABLE 250 ELANCO: BUSINESS OVERVIEW 314
・ FIGURE 82 ELANCO: COMPANY SNAPSHOT 315
・ TABLE 251 ELANCO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 315
13.2.2 NEXTFOODS, INC. 317
・ TABLE 252 NEXTFOODS, INC.: BUSINESS OVERVIEW 317
・ TABLE 253 NEXTFOODS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 318
・ TABLE 254 NEXTFOODS, INC.: DEALS 319
13.2.3 I-HEALTH, INC. 321
・ TABLE 255 I-HEALTH, INC.: BUSINESS OVERVIEW 321
・ TABLE 256 I-HEALTH, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 321
13.2.4 SUJA LIFE, LLC. 326
・ TABLE 257 SUJA LIFE, LLC.: BUSINESS OVERVIEW 326
・ TABLE 258 SUJA LIFE, LLC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 326
・ TABLE 259 SUJA LIFE, LLC.: DEALS 327
13.2.5 RENEW LIFE FORMULAS, LLC 329
・ TABLE 260 RENEW LIFE FORMULAS, LLC.: BUSINESS OVERVIEW 329
・ TABLE 261 RENEW LIFE FORMULAS, LLC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 330
13.2.6 BIOHM HEALTH 333
・ TABLE 262 BIOHM HEALTH: BUSINESS OVERVIEW 333
13.2.7 SUN GENOMICS 334
・ TABLE 263 SUN GENOMICS: BUSINESS OVERVIEW 334
13.2.8 UNIQUE BIOTECH LTD 335
・ TABLE 264 UNIQUE BIOTECH LTD: BUSINESS OVERVIEW 335
13.2.9 SO GOOD SO YOU 336
・ TABLE 265 SO GOOD SO YOU: BUSINESS OVERVIEW 336
13.2.10 PROTOCOL FOR LIFE BALANCE 337
・ TABLE 266 PROTOCOL FOR LIFE BALANCE: BUSINESS OVERVIEW 337
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.

14 ADJACENT AND RELATED MARKETS 338
14.1 INTRODUCTION 338
・ TABLE 267 ADJACENT MARKETS TO PROBIOTICS 338
14.2 RESEARCH LIMITATIONS 338
14.3 DIETARY SUPPLEMENT MARKET 338
14.3.1 MARKET DEFINITION 338
14.3.2 MARKET OVERVIEW 338
・ TABLE 268 DIETARY SUPPLEMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 339
・ TABLE 269 DIETARY SUPPLEMENTS MARKET, BY TYPE, 2023–2028 (USD MILLION) 340
14.4 BONE & JOINT HEALTH SUPPLEMENTS MARKET 340
14.4.1 MARKET DEFINITION 340
14.4.2 MARKET OVERVIEW 340
・ TABLE 270 BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 341
・ TABLE 271 BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 341

15 APPENDIX

△ 一番上に戻る